Buy One Get One free -Llimited Time Offer X
Arpimune ME 25 Mg Capsule, a prescription drug, is manufactured in various forms such as Capsule. Psoriasis, Liver transplant are some of its major therapeutic uses. Secondary and off-label uses of Arpimune ME 25 Mg Capsule have also been mentioned below.
The right dosage of Arpimune ME 25 Mg Capsule depends on the age, gender, and medical history of the patient. Dosage also depends on the route of administration and your chief complaint for which the drug is prescribed. Detailed information has been provided in the dosage section.
Arpimune ME 25 Mg Capsule also has some side effects, the most common being Increased hair growth, Loss of appetite. While these are the most often observed Arpimune ME 25 Mg Capsule side effects, there are can be others also. These have been listed below. Normally, these side effects of Arpimune ME 25 Mg Capsule are not long lasting and go away when the treatment is finished. Please speak with your doctor if these side effects worsen or persist for a longer duration.
It is also important to note that Arpimune ME 25 Mg Capsule has a Severe effect for pregnant women and Severe effect on lactating mothers. In addition, Arpimune ME 25 Mg Capsule's effects on the liver, heart and kidney are discussed below in the Arpimune ME 25 Mg Capsule related warnings section.
Arpimune ME 25 Mg Capsule is not recommended if you suffer from certain medical conditions as it can have adverse effects. Liver Disease are examples of such conditions. Other conditions have been mentioned below in the Arpimune ME 25 Mg Capsule contraindications section.
Additionally, Arpimune ME 25 Mg Capsule may also adversely react with other medicines. See below for a complete list.
In addition to the above precautions for Arpimune ME 25 Mg Capsule, it is important to know that it is safe while driving, and is habit-forming.
Arpimune ME 25 Mg Capsule is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Is the use of Arpimune ME 25 Mg Capsule safe for pregnant women?
Pregnant women may get severe side effects after taking Arpimune ME. If you are pregnant, do not take Arpimune ME without a doctor's advice.
Is the use of Arpimune ME 25 Mg Capsule safe during breastfeeding?
Women who are breastfeeding, may experience serious side effects after taking Arpimune ME. So it is adviced to consult the doctor before using it.
What is the effect of Arpimune ME 25 Mg Capsule on the Kidneys?
Arpimune ME rarely harms the kidneys.
What is the effect of Arpimune ME 25 Mg Capsule on the Liver?
Arpimune ME may have mild side effects on the liver. Most people will never see any effect on the liver.
What is the effect of Arpimune ME 25 Mg Capsule on the Heart?
Arpimune ME can have moderate side effects on the heart. If you notice any harmful effects then stop taking this drug right away. Consult your doctor before using this medicine again.
If you are suffering from any of the following diseases, you should not take Arpimune ME 25 Mg Capsule unless your doctor advises you to do so -
Is this Arpimune ME 25 Mg Capsule habit forming or addictive?
No, there is no any evidence that Arpimune ME 25 Mg Capsule is addictive.
Interaction between Food and Arpimune ME 25 Mg Capsule
Information is not available on the interaction of any foods with Arpimune ME 25 Mg Capsule, due to a lack of research on this.
Interaction between Alcohol and Arpimune ME 25 Mg Capsule
No research has been done on this till date. Therefore, it is not known what the effect of taking Arpimune ME 25 Mg Capsule with alcohol will be.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Sandimmune® (cyclosporine)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 876-881
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 377-380
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Sandimmune® (cyclosporine)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 879-881
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 377-380